Why the study?
Does isoproterenol compared to levarterenol improve cardiac output and regional blood flow in hemorrhagic shock?
Population
Subjects with hemorrhagic shock (experimental model implied)
Comparison
Isoproterenol vs Levarterenol
Design
Preclinical
Authors
Loading...
Whether isoproterenol or levarterenol optimizes regional perfusion in hemorrhagic shock remains unresolved; hypothesis-generating for modern resuscitation trials.
Does isoproterenol compared to levarterenol improve cardiac output and regional blood flow in hemorrhagic shock?
This study was designed to compare the hemodynamic effects of a vasodilator (isoproterenol) versus a vasoconstrictor (levarterenol) on regional blood flow and oxygen use in hemorrhagic shock.
Dale G. Johnson (1966) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: